Table of Contents Author Guidelines Submit a Manuscript
Critical Care Research and Practice
Volume 2014 (2014), Article ID 479413, 8 pages
http://dx.doi.org/10.1155/2014/479413
Clinical Study

An Observational Study on Early Empiric versus Culture-Directed Antifungal Therapy in Critically Ill with Intra-Abdominal Sepsis

1Department of Pharmacy, Singapore General Hospital, Outram Road, Singapore 169608
2Department of Infectious Diseases, Singapore General Hospital, Outram Road, Singapore 169608
3Department of Anaesthesiology, Singapore General Hospital, Outram Road, Singapore 169608

Received 6 February 2014; Accepted 17 April 2014; Published 15 May 2014

Academic Editor: Djillali Annane

Copyright © 2014 Winnie Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Ostrosky-Zeichner, “New approaches to the risk of Candida in the intensive care unit,” Current Opinion in Infectious Diseases, vol. 16, no. 6, pp. 533–537, 2003. View at Google Scholar · View at Scopus
  2. K. W. Garey, M. M. Neuhauser, D. T. Bearden et al., “Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study,” Mycoses, vol. 49, no. 3, pp. 226–231, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Marriot, E. G. Playford, S. Chan et al., “Determinants of mortality in non-neutropenic ICU patients with candidemia,” Critical Care, vol. 13, no. 4, Article ID R115, 2009. View at Google Scholar
  4. M. Méan, O. Marchetti, and T. Calandra, “Bench-to-bedside review: candida infections in the intensive care unit,” Critical Care, vol. 12, no. 1, article 204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Muñoz, A. Burillo, and E. Bouza, “Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit,” International Journal of Antimicrobial Agents, vol. 15, no. 2, pp. 83–90, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. E. G. Playford, J. Lipman, and T. C. Sorrell, “Management of invasive candidiasis in the intensive care unit,” Drugs, vol. 70, no. 7, pp. 823–839, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Pfaller and D. J. Diekema, “Epidemiology of invasive candidiasis: a persistent public health problem,” Clinical Microbiology Reviews, vol. 20, no. 1, pp. 133–163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. Rangel-Frausto, T. Wiblin, H. M. Blumberg et al., “National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units,” Clinical Infectious Diseases, vol. 29, no. 2, pp. 253–258, 1999. View at Google Scholar · View at Scopus
  9. M. A. Weigand, C. Lichtenstern, and B. W. Bottiger, “Antifungal therapy in surgical ICU patients,” in Yearbook of Intensive Care & Emergency Medicine, pp. 613–623, 2006. View at Google Scholar
  10. O. Marchetti, P. Eggimann, and T. Calandra, “Invasive candidiasis in critically ill patients: does progressing knowledge improve clinical management and outcome?” Current Opinion in Critical Care, vol. 16, no. 5, pp. 442–444, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. G. Playford, J. Lipman, and T. C. Sorrell, “Prophylaxis, empirical and preemptive treatment of invasive candidiasis,” Current Opinion in Critical Care, vol. 16, no. 5, pp. 470–474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K. W. Garey, M. Rege, M. P. Pai et al., “Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study,” Clinical Infectious Diseases, vol. 43, no. 1, pp. 25–31, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Morrell, V. J. Fraser, and M. H. Kollef, “Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 9, pp. 3640–3645, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. P.-R. Hsueh, J. R. Graybill, E. G. Playford et al., “Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region,” International Journal of Antimicrobial Agents, vol. 34, no. 3, pp. 205–209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-S. Shan, E. D. Sy, S.-T. Wang, J.-C. Lee, and P.-W. Lin, “Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery,” World Journal of Surgery, vol. 30, no. 1, pp. 119–126, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Eggimann, P. Francioli, J. Bille et al., “Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients,” Critical Care Medicine, vol. 27, no. 6, pp. 1066–1072, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. R. K. Pelz, C. W. Hendrix, S. M. Swoboda et al., “Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically III surgical patients,” Annals of Surgery, vol. 233, no. 4, pp. 542–548, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Garbino, D. P. Lew, J.-A. R. Jacques-A. Romand, S. Hugonnet, R. Auckenthaler, and D. Pittet, “Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination,” Intensive Care Medicine, vol. 28, no. 12, pp. 1708–1717, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. E. G. Playford, A. C. Webster, T. C. Sorrell, and J. C. Craig, “Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD004920, 2006. View at Google Scholar · View at Scopus
  20. A. F. Shorr, K. Chung, W. L. Jackson, P. E. Waterman, and M. H. Kollef, “Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis,” Critical Care Medicine, vol. 33, no. 9, pp. 1928–1935, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. P. G. Pappas, C. A. Kauffman, D. Andes et al., “Clinical practice guidelines for the management of candidiasis: 2009 Update by the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 48, no. 5, pp. 503–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Piarroux, F. Grenouillet, P. Balvay et al., “Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients,” Critical Care Medicine, vol. 32, no. 12, pp. 2443–2449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Eggimann and O. Marchetti, “Is (1→3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis?” Critical Care, vol. 15, no. 6, article 1017, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Blot, G. Dimopoulos, J. Rello, and D. Vogelaers, “Is Candida really a threat in the ICU?” Current Opinion in Critical Care, vol. 14, no. 5, pp. 600–604, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Z. Vardakas, A. Michalopoulos, K. G. Kiriakidou, E. P. Siampli, G. Samonis, and M. E. Falagas, “Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients,” Clinical Microbiology and Infection, vol. 15, no. 3, pp. 289–292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. W. Lam, G. A. Eschenauer, and P. L. Carver, “Evolving role of early antifungals in the adult intensive care unit,” Critical Care Medicine, vol. 37, no. 5, pp. 1580–1593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. O. A. Cornely, M. Bassetti, T. Calandra et al., “ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients,” Clinical Microbiology and Infection, vol. 18, supplement 7, pp. 19–37, 2012. View at Google Scholar
  28. J. Nolla-Salas, A. Sitges-Serra, C. Leon-Fil et al., “Candidemia in non-neutropenic critically-ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU,” Intensive Care Medicine, vol. 23, pp. 23–30, 1997. View at Google Scholar
  29. M. D. Zilberberg, M. H. Kollef, H. Arnold et al., “Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study,” BMC Infectious Diseases, vol. 10, article 150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. M. D. Parkins, D. M. Sabuda, S. Elsayed, and K. B. Laupland, “Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections,” Journal of Antimicrobial Chemotherapy, vol. 60, no. 3, pp. 613–618, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Krishnan-Natesan, E. K. Manavathu, J. L. Cutright, and P. H. Chandrasekar, “Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model,” International Journal of Antimicrobial Agents, vol. 36, no. 1, pp. 33–36, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. B. De Pauw, T. J. Walsh, J. P. Donnelly et al., “Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group,” Clinical Infectious Diseases, vol. 46, no. 12, pp. 1813–1821, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Kauffman, K. A. Marr, and R. A. Thorner, “Epidemiology and pathogenesis of candidemia in adults,” 2011, http://www.uptodate.com/.
  34. O. Leroy, J.-P. Gangneux, P. Montravers et al., “Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006),” Critical Care Medicine, vol. 37, no. 5, pp. 1612–1618, 2009. View at Publisher · View at Google Scholar · View at Scopus